[New viewpoints on using anabolic steroids in gynecologic radiotherapy, including animal experimental studies in healthy and tumor-vaccinated mice and rats].
D000818:Animals; D001317:Austria; D001835:Body Weight; D002277:Carcinoma / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D005833:Genital Neoplasms, Female / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy; D006801:Humans; D008696:Methandrostenolone / Q000627:therapeutic use*; D008710:Methenolone / Q000627:therapeutic use*; D051379:Mice; D009374:Neoplasms, Experimental; D010051:Ovarian Neoplasms / Q000188:drug therapy; D011182:Postoperative Care; D011832:Radiation Injuries / Q000188:drug therapy; D011835:Radiation Protection; D051381:Rats; D012004:Rectal Neoplasms / Q000188:drug therapy; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy; D014594:Uterine Neoplasms / Q000188:drug therapy; D014625:Vaginal Neoplasms / Q000188:drug therapy; D014846:Vulvar Neoplasms / Q000188:drug therapy
D008710:Methenolone; D008696:Methandrostenolone
Neue Gesichtspunkte zur Anwendung anaboler Steroide in der gynäkologischen Strahlentherapie, mit tierexperimentellen Untersuchungen an gesunden und tumorgeimpften Mäusen und Ratten.